| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 11/04/1991 | CA2041703A1 Flavor enhancing and increasing efficacy of cough drops |
| 11/02/1991 | WO1991017149A1 3-naphthyl-3-carboxyalkylthio or oxy substituted alkanoic acid leukotriene antagonists |
| 11/02/1991 | CA2081480A1 3-naphthyl-3-carboxyalkylthio or oxy substituted alkanoic acid leukotriene antagonists |
| 10/31/1991 | WO1991016303A1 Cyclic hydroxamic acids and their use |
| 10/31/1991 | CA2062715A1 Saccharide compositions, methods and apparatus for their synthesis |
| 10/30/1991 | EP0454429A2 Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases |
| 10/30/1991 | EP0453960A1 Sulfonylamino substituted bicyclyl hydroxamic acid derivatives |
| 10/28/1991 | WO1991017157A1 Gamma-butyrolactol ether derivatives |
| 10/28/1991 | WO1991016927A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
| 10/28/1991 | CA2081478A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
| 10/28/1991 | CA2080346A1 Gamma-butyrolactol ether derivatives |
| 10/23/1991 | EP0418230A4 Method for potentiating and inhibiting insulin-like growth factor activity |
| 10/23/1991 | EP0291507B1 Electronic inclinometer |
| 10/22/1991 | US5059712 Isolating aminoarginine and use to block nitric oxide formation in body |
| 10/22/1991 | US5059610 Treatment of hypersensitive disorders; antiinflammatory, antiallergic agents |
| 10/22/1991 | CA1291131C 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8,-inter- m-phenylene pgi _derivatives |
| 10/17/1991 | WO1991015770A1 Therapeutic uses of actin-binding compounds |
| 10/17/1991 | WO1991015475A1 Novel vitamin d analogues |
| 10/17/1991 | CA2029857A1 Sustained-release preparation composition comprising pyridazinone compound |
| 10/16/1991 | EP0451634A2 Cycloalkano[b]dihydroindoles and -indolesulphonamides substituted by heterocycles |
| 10/16/1991 | EP0451538A2 Use of pyridoindole derivatives in the treatment of ischemic disorders |
| 10/15/1991 | US5057614 Substituted pyrroles |
| 10/15/1991 | US5057530 Glycerol derivatives |
| 10/15/1991 | US5057513 Spiro-thiazepine derivatives useful as paf antagonists |
| 10/11/1991 | CA2039873A1 Cycloalkano(b)dihydroindoles and -indolesulphonamides substituted by heterocycles |
| 10/09/1991 | EP0450991A2 Use of phosphatidylglycerol(diC 18:10)in the treatment of obstructive airway diseases |
| 10/09/1991 | EP0450487A1 Benzoxazine derivatives, method for their preparation and their use for treating or prophylaxis of diseases |
| 10/09/1991 | EP0450066A1 Carbostyril derivatives |
| 10/09/1991 | EP0450039A1 Dihydro-1,2 oxo-2 quinoxaline derivates, their preparation and their application in therapeutics. |
| 10/09/1991 | EP0449968A1 PROCESS FOR THE PREPARATION OF HUMAN DNase |
| 10/09/1991 | EP0449856A1 Pneumolysin mutants and pneumococcal vaccines made therefrom |
| 10/06/1991 | WO1991015451A1 Novel derivatives of phenyl-cycloalkanes and -cycloalkenes |
| 10/06/1991 | CA2079785A1 Derivatives of phenyl-cycloalkanes and cycloalkenes |
| 10/03/1991 | CA2039458A1 Methods for treating interleukin-1 mediated diseases |
| 10/02/1991 | EP0449562A2 Use of R-Fluoxetine as selective serotonin IC-receptor ligands |
| 10/02/1991 | EP0449561A2 Use of (R)-norfluoxetine in the preparation of a medicament with affinity to 5HT1c receptors |
| 10/02/1991 | EP0448895A1 Use of a non-alcoholic delivery system for active ingredients which are ingested orally |
| 10/02/1991 | EP0448583A1 Organometallic compounds, process for producing them and pharmaceutical compositions containing them |
| 10/02/1991 | DE4010355A1 Bicyclo(3.3.0)octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Bicyclo (3.3.0) octane derivatives, process for their production and their pharmaceutical use |
| 10/01/1991 | WO1991015223A1 Respiratory burst suppression factor |
| 10/01/1991 | US5053427 Guanidino-substituted benzopyrans and their use as pharmaceuticals |
| 10/01/1991 | US5053415 Pyridine derivatives |
| 10/01/1991 | CA2055593A1 Respiratory burst suppression factor |
| 10/01/1991 | CA2039319A1 Benzoxazine derivatives, process for their preparation and their use for the treatment of for the prophylaxis of diseases |
| 10/01/1991 | CA1289954C Xanthine derivatives |
| 10/01/1991 | CA1289952C N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas, processes for their preparation, and their use in medicaments |
| 09/30/1991 | CA2039103A1 Improvements in and relating to the selective occupation of serotonin 1c receptors |
| 09/30/1991 | CA2039102A1 Compounds affecting serotonin receptors |
| 09/29/1991 | WO1991014675A1 Bicyclo[3.3.)]octane derivatives, process for producing them and their pharmaceutical use |
| 09/29/1991 | CA2058922A1 Bicyclo{3.3.0}octane derivatives, process for their production and their pharmaceutical use |
| 09/28/1991 | WO1991014674A2 5-lipoxygenase inhibitors |
| 09/28/1991 | CA2078126A1 5-lipoxygenase inhibitors |
| 09/25/1991 | EP0448261A2 Tenidap as an inhibitor of the release of elastase by neutrophils |
| 09/25/1991 | CN1054767A Process for preparing synthesis of 5-acyloxy and 5-alkoxy-2,2-dihydro-4,6,7-trimethyl-2-(rs)-benzofuranacetic |
| 09/24/1991 | US5051438 Treating leukotriene by mediated diseases; antiinflammatory agents |
| 09/20/1991 | CA2038527A1 Therapeutic agent for ischemic diseases |
| 09/19/1991 | WO1991004058A3 Treatment of conditions and disease |
| 09/18/1991 | EP0447189A1 5-Hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors |
| 09/18/1991 | EP0447188A2 7-Oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic diseases |
| 09/18/1991 | EP0446809A1 New process for the synthesis of 5-acyloxy and 5-alkoxy-2,3-dihydro-4,6,7-trimethyl-2-(RS)-benzofuranacetic acids |
| 09/18/1991 | CN1054586A Substituted amine compound and process for preparation thereof |
| 09/17/1991 | WO1991013876A1 Imidazoles |
| 09/17/1991 | WO1991013619A1 Nitroxides as protectors against oxidative stress |
| 09/17/1991 | US5049637 5-hydroxytryptamine antagonist |
| 09/17/1991 | US5049568 Antihistamine, antiallergy, bronchodialtors |
| 09/17/1991 | CA2078208A1 Imidazoles |
| 09/13/1991 | CA2037683A1 Process for the synthesis of 5-acyloxy and 5-alkoxy-2,3-dihydro-4,6,7-trimethyl-2-(rs)- benzofuranacetic acids |
| 09/13/1991 | CA2036486A1 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
| 09/11/1991 | EP0446180A1 5-Phenyl-1H-pyrazol-4-propionic acid derivatives, their preparation and their use |
| 09/11/1991 | EP0446141A1 Imidazo[1,2-c]quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/11/1991 | EP0446017A1 New diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator |
| 09/11/1991 | EP0445749A1 N-Monosubstituted cyclopentenylamines, a process for their preparation and their use as medicaments |
| 09/10/1991 | WO1991013925A1 Method for polymerization of epoxide compounds |
| 09/10/1991 | US5047593 Lipoxygenase inhibiting compounds |
| 09/10/1991 | US5047575 Norbornene carboxylic acids and esters |
| 09/10/1991 | US5047429 Treatment of oedema |
| 09/10/1991 | US5047428 Expectorant comprising hydroxyalkylcysteine derivative |
| 09/10/1991 | US5047404 Chemical compounds |
| 09/10/1991 | CA2037812A1 Imidazo[1,2-c]quinazoline derivatives, process for the preparation thereof and pharmaceutical compositions containing the same |
| 09/10/1991 | CA1288894C Physiologically active peptides having bronchodilative and hypotensive activity |
| 09/09/1991 | CA2037721A1 Substituted-amine compound and a process for the preparation thereof |
| 09/07/1991 | CA2037559A1 5-phenyl-1h-pyrazol-4-propionic acid derivatives their preparation and use |
| 09/06/1991 | WO1991013883A1 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity |
| 09/06/1991 | CA2077543A1 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity |
| 09/06/1991 | CA2037478A1 Diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator |
| 09/05/1991 | WO1991012812A1 Inhibitors of catalytic antibodies |
| 09/05/1991 | WO1991011435A3 New centrally acting 6,7,8,9-tetrahydro-3h-benz(e)indole heterocyclics |
| 09/04/1991 | EP0445062A1 4(1H)Quinolone derivatives |
| 09/04/1991 | EP0444549A1 Imidazopyridazines their production and use |
| 09/04/1991 | CN1013769B Method for preparation of improvement leukotriene antagonists |
| 09/03/1991 | US5045547 Leukotriene-inhibiting substituted (quinolin-2-yl-methoxy)phenyl-N,N'-sulphonylureas and use thereas |
| 08/29/1991 | CA2037199A1 Inhibitors of catalytic antibodies |
| 08/28/1991 | EP0443132A1 Peptides having tachykinin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same |
| 08/28/1991 | CN1054066A Improvements in and relating to leukotriene antagonists |
| 08/28/1991 | CN1013676B 6-thioxanthine derivatives |
| 08/27/1991 | WO1991013061A1 4(1h)quinolone derivatives |
| 08/27/1991 | US5043456 6-oxa and thiabicyclo [3.1.0.] compounds |
| 08/27/1991 | US5043451 Bicyclo (2.2.1.) hept-exo-2-yl and bicyclo (2.2.2.) oct-endo-2-yl compounds |
| 08/27/1991 | CA2053873A1 Quinolone derivatives |
| 08/27/1991 | CA1288107C Leukotriene antagonists |